ANTOLINE STEVE
Insider CIK 1529363 · NONE Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PRGB Protea Biosciences Group, | J Other deriv | 2017-03-24 | 2017-04-04 | 16,564,248 | — | $0 | 42,422,699 | SEC↗ |
| PRGB Protea Biosciences Group, | J Other deriv | 2017-03-24 | 2017-04-04 | 16,564,248 | — | $0 | 42,422,699 | SEC↗ |
| PRGB Protea Biosciences Group, | J Other | 2017-03-24 | 2017-04-04 | 16,564,248 | — | $0 | 26,325,894 | SEC↗ |
| PRGB Protea Biosciences Group, | J Other | 2016-02-03 | 2016-03-01 | 165,573 | — | $0 | 6,319,426 | SEC↗ |
| PRGB Protea Biosciences Group, | A Award deriv | 2015-12-18 | 2016-03-01 | 66,667 | — | $0 | 66,667 | SEC↗ |
| PRGB Protea Biosciences Group, | A Award | 2015-12-18 | 2016-03-01 | 100,000 | — | $0 | 6,153,853 | SEC↗ |
| PRGB Protea Biosciences Group, | J Other | 2015-10-12 | 2016-03-01 | 244,456 | — | $0 | 6,053,853 | SEC↗ |
| PRGB Protea Biosciences Group, | J Other | 2015-06-30 | 2016-03-01 | 193,894 | — | $0 | 5,809,397 | SEC↗ |
| PRGB Protea Biosciences Group, | J Other | 2015-04-14 | 2016-03-01 | 363,273 | — | $0 | 5,615,503 | SEC↗ |
| PRGB Protea Biosciences Group, | J Other deriv | 2015-04-06 | 2015-04-08 | 1,630,000 | — | $0 | 1,630,000 | SEC↗ |
| PRGB Protea Biosciences Group, | J Other deriv | 2015-03-20 | 2015-03-27 | 1,100,523 | — | $0 | 1,100,523 | SEC↗ |
| PRGB Protea Biosciences Group, | J Other | 2015-03-20 | 2015-03-27 | 2,201,046 | — | $0 | 14,885,481 | SEC↗ |
| PRGB Protea Biosciences Group, | P Buy deriv | 2014-09-26 | 2014-09-29 | 75,000 | $60000.00 | $4.50B | 7,575,847 | SEC↗ |
| PRGB Protea Biosciences Group, | P Buy deriv | 2014-09-26 | 2014-09-29 | 75,000 | $60000.00 | $4.50B | 7,575,847 | SEC↗ |
| PRGB Protea Biosciences Group, | P Buy deriv | 2014-09-04 | 2014-09-08 | 175,000 | $140000.00 | $24.50B | 7,500,847 | SEC↗ |
| PRGB Protea Biosciences Group, | P Buy deriv | 2014-09-04 | 2014-09-08 | 175,000 | $140000.00 | $24.50B | 7,500,847 | SEC↗ |
| PRGB Protea Biosciences Group, | P Buy deriv | 2014-08-21 | 2014-08-25 | 150,000 | $120000.00 | $18.00B | 7,325,847 | SEC↗ |
| PRGB Protea Biosciences Group, | P Buy deriv | 2014-08-21 | 2014-08-25 | 150,000 | $120000.00 | $18.00B | 7,325,847 | SEC↗ |
| PRGB Protea Biosciences Group, | P Buy deriv | 2014-08-01 | 2014-08-05 | 65,000 | $52000.00 | $3.38B | 7,175,847 | SEC↗ |
| PRGB Protea Biosciences Group, | P Buy deriv | 2014-08-01 | 2014-08-05 | 65,000 | $52000.00 | $3.38B | 7,175,847 | SEC↗ |
| PRGB Protea Biosciences Group, | P Buy deriv | 2014-07-08 | 2014-07-10 | 300,000 | $240000.00 | $72.00B | 7,110,847 | SEC↗ |
| PRGB Protea Biosciences Group, | P Buy deriv | 2014-07-08 | 2014-07-10 | 300,000 | $240000.00 | $72.00B | 7,110,847 | SEC↗ |
| PRGB Protea Biosciences Group, | P Buy deriv | 2014-05-30 | 2014-07-10 | 50,000 | $40000.00 | $2.00B | 6,810,847 | SEC↗ |
| PRGB Protea Biosciences Group, | P Buy deriv | 2014-05-30 | 2014-07-10 | 50,000 | $40000.00 | $2.00B | 6,810,847 | SEC↗ |
| PRGB Protea Biosciences Group, | P Buy deriv | 2014-04-11 | 2014-07-10 | 200,000 | $160000.00 | $32.00B | 6,760,847 | SEC↗ |
| PRGB Protea Biosciences Group, | P Buy deriv | 2014-04-11 | 2014-07-10 | 200,000 | $160000.00 | $32.00B | 6,760,847 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2014-04-02 | 2014-04-07 | 400,000 | $320000.00 | $128.00B | 7,320,405 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2014-04-02 | 2014-04-07 | 400,000 | $320000.00 | $128.00B | 7,320,405 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2014-04-02 | 2014-04-07 | 400,000 | $320000.00 | $128.00B | 6,560,847 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2014-04-02 | 2014-04-07 | 400,000 | $320000.00 | $128.00B | 6,560,847 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2014-02-11 | 2014-02-13 | 250,000 | $275000.00 | $68.75B | 6,160,847 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2014-02-11 | 2014-02-13 | 250,000 | $275000.00 | $68.75B | 6,160,847 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2013-12-30 | 2014-02-13 | 305,500 | $152750.00 | $46.67B | 5,758,097 | SEC↗ |
| NONE Protea Biosciences Group, | C Conversion deriv | 2013-12-30 | 2014-02-13 | 305,500 | $152750.00 | $46.67B | 5,452,597 | SEC↗ |
| NONE Protea Biosciences Group, | C Conversion deriv | 2013-12-30 | 2014-02-13 | 305,500 | $152750.00 | $46.67B | 5,452,597 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2013-12-30 | 2014-02-13 | 152,750 | $114563.00 | $17.50B | 5,910,847 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2013-12-30 | 2014-02-13 | 152,750 | $114563.00 | $17.50B | 5,910,847 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2013-12-30 | 2014-02-13 | 305,500 | $152750.00 | $46.67B | 5,758,097 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy | 2013-12-30 | 2014-02-13 | 305,500 | $0.50 | $152.8K | 4,565,232 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy | 2013-12-30 | 2014-02-13 | 305,500 | $0.50 | $152.8K | 4,565,232 | SEC↗ |
| NONE Protea Biosciences Group, | C Conversion deriv | 2013-11-01 | 2014-02-13 | 251,667 | $125833.00 | $31.67B | 5,752,597 | SEC↗ |
| NONE Protea Biosciences Group, | C Conversion deriv | 2013-11-01 | 2014-02-13 | 251,667 | $125833.00 | $31.67B | 5,752,597 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2013-11-01 | 2014-02-13 | 125,833 | $94375.00 | $11.88B | 6,002,597 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2013-11-01 | 2014-02-13 | 125,833 | $94375.00 | $11.88B | 6,002,597 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2013-11-01 | 2014-02-13 | 251,667 | $125834.00 | $31.67B | 5,876,764 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2013-11-01 | 2014-02-13 | 251,667 | $125834.00 | $31.67B | 5,876,764 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy | 2013-11-01 | 2014-02-13 | 251,667 | $0.50 | $125.8K | 4,259,732 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy | 2013-11-01 | 2014-02-13 | 251,667 | $0.50 | $125.8K | 4,259,732 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2013-10-25 | 2014-02-13 | 300,000 | $150000.00 | $45.00B | 5,625,097 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2013-10-25 | 2014-02-13 | 300,000 | $150000.00 | $45.00B | 5,625,097 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2013-10-07 | 2014-02-13 | 250,000 | $125000.00 | $31.25B | 5,325,097 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2013-10-07 | 2014-02-13 | 250,000 | $125000.00 | $31.25B | 5,325,097 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2013-10-07 | 2014-02-13 | 93,750 | $103125.00 | $9.67B | 5,075,097 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2013-10-07 | 2014-02-13 | 93,750 | $103125.00 | $9.67B | 5,075,097 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2013-08-23 | 2014-02-13 | 1,000,000 | $1100000.00 | $1100.00B | 4,981,347 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2013-08-23 | 2014-02-13 | 1,000,000 | $1100000.00 | $1100.00B | 4,981,347 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2013-07-23 | 2014-02-13 | 1,493,013 | — | $0 | 5,731,347 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2013-07-23 | 2014-02-13 | 1,493,013 | — | $0 | 5,731,347 | SEC↗ |
| NONE Protea Biosciences Group, | C Conversion deriv | 2013-07-23 | 2014-02-13 | 1,990,684 | $995342.00 | $1981.41B | 3,981,347 | SEC↗ |
| NONE Protea Biosciences Group, | C Conversion deriv | 2013-07-23 | 2014-02-13 | 1,990,684 | $995342.00 | $1981.41B | 3,981,347 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy | 2013-07-23 | 2014-02-13 | 1,990,684 | $0.50 | $995.3K | 4,008,065 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy | 2013-07-23 | 2014-02-13 | 1,990,684 | $0.50 | $995.3K | 4,008,065 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy | 2013-07-23 | 2014-02-13 | 200,000 | $0.50 | $100.0K | 2,017,381 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy | 2013-07-23 | 2014-02-13 | 200,000 | $0.50 | $100.0K | 2,017,381 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2013-07-09 | 2014-02-13 | 150,000 | $165000.00 | $24.75B | 4,238,334 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2013-07-09 | 2014-02-13 | 150,000 | $165000.00 | $24.75B | 4,238,334 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2013-03-06 | 2014-02-13 | 1,100,000 | $1210000.00 | $1331.00B | 4,088,334 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2013-03-06 | 2014-02-13 | 1,100,000 | $1210000.00 | $1331.00B | 4,088,334 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2012-11-30 | 2014-02-13 | 300,000 | $150000.00 | $45.00B | 2,988,334 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2012-11-30 | 2014-02-13 | 300,000 | $150000.00 | $45.00B | 2,988,334 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2012-09-25 | 2014-02-13 | 250,000 | $125000.00 | $31.25B | 2,688,334 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2012-09-25 | 2014-02-13 | 250,000 | $125000.00 | $31.25B | 2,688,334 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2012-04-16 | 2014-02-13 | 200,000 | $100000.00 | $20.00B | 2,438,334 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2012-04-16 | 2014-02-13 | 200,000 | $100000.00 | $20.00B | 2,438,334 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2011-12-27 | 2014-02-13 | 25,000 | $56250.00 | $1.41B | 2,238,334 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2011-12-27 | 2014-02-13 | 25,000 | $56250.00 | $1.41B | 2,238,334 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy | 2011-12-27 | 2014-02-13 | 50,000 | $2.00 | $100.0K | 1,817,381 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy | 2011-12-27 | 2014-02-13 | 50,000 | $2.00 | $100.0K | 1,817,381 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2011-12-20 | 2014-02-13 | 1,000,000 | $500000.00 | $500.00B | 2,213,334 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2011-12-20 | 2014-02-13 | 1,000,000 | $500000.00 | $500.00B | 2,213,334 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2011-09-30 | 2014-02-13 | 6,667 | $13334.00 | $88.90M | 1,213,334 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2011-09-30 | 2014-02-13 | 6,667 | $13334.00 | $88.90M | 1,213,334 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2011-09-30 | 2014-02-13 | 36,667 | $73334.00 | $2.69B | 1,206,667 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2011-09-30 | 2014-02-13 | 36,667 | $73334.00 | $2.69B | 1,206,667 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy | 2011-09-30 | 2014-02-13 | 73,333 | $1.50 | $110.0K | 1,754,048 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy | 2011-09-30 | 2014-02-13 | 73,333 | $1.50 | $110.0K | 1,754,048 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy | 2011-09-30 | 2014-02-13 | 13,333 | $1.50 | $20.0K | 1,767,381 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy | 2011-09-30 | 2014-02-13 | 13,333 | $1.50 | $20.0K | 1,767,381 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2010-04-23 | 2014-02-13 | 100,000 | $150000.00 | $15.00B | 1,170,000 | SEC↗ |